Company Profile | February 27, 2014

2014 CRO Leadership Awards Winner

charles river logo

Categories Won:

  1. Quality

  2. Productivity

  3. Regulatory

 

Drug Life Cycle Stages:
Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3), Manufacturing Support

Main Service Areas:
Bioanalytical, Preclinical

Services & Capabilities:
Discovery research services, research models and services, safety assessment, laboratory and pathology support, agrochemical and animal health product development, biologics testing solutions, and endotoxin and microbial detection

Therapeutic Areas:
Cardiovascular, endocrine/metabolic, oncology, skeletal disease, central nervous system, inflammation, ophthalmology, vaccines/cell therapy/ biosimilars

James C. Foster

chairman, president, and chief executive officer

“We believe that one size does not fit all, and that a deep understanding of our clients is pivotal to a successful working relationship. At Charles
River, we provide our clients with a flexible research platform best suited for their needs, which is integral to enhancing the research and development process. We are pleased that our clients recognize Charles River’s industry leadership with this award.”